Johan Staaf

Citeras av

	Alla	Sedan 2019
Citat	13073	6920
h-index	55	38
i10-index	128	95

1400

700

350

1050

200620072008200920102011201220132014201520162017201820192020202120222023202435 94 215 317 422 421 531 567 535 568 587 845 914 982 1201 1354 1207 1108 1058

Offentlig åtkomst

Visa alla

70 artiklar

6 artiklar

tillgänglig

inte tillgänglig

Enligt krav från finansiärer

Medförfattare

Åke BorgDepartment of Oncology, Clinical Sciences, Lund University, SwedenVerifierad e-postadress på med.lu.se
Göran JönssonProfessor, Dept. of Oncology, Clinical Sciences, Lund University, SwedenVerifierad e-postadress på med.lu.se
Markus RingnérScience for Life Laboratory and Lund UniversityVerifierad e-postadress på scilifelab.se
Johan Vallon-ChristerssonDivision of Oncology, Department of Clinical Sciences Lund, Lund University, SwedenVerifierad e-postadress på med.lu.se
Lao H SaalAssociate Professor, Lund UniversityVerifierad e-postadress på med.lu.se
Mattias HöglundDepartment of Oncology, Clinical Sciences, Lund University, SwedenVerifierad e-postadress på med.lu.se
Karin JirströmLund UniversityVerifierad e-postadress på med.lu.se
Brunnström HansMD, PhD, Lund University, Dept of PathologyVerifierad e-postadress på med.lu.se
Jari HäkkinenDepartment of Oncology and Pathology, Clinical Sciences, Lund University, SwedenVerifierad e-postadress på med.lu.se
Barkardottir R BLaboratory of Cell Biology, Department of Pathology, Landspitali University Hospital, ReykjavikVerifierad e-postadress på landspitali.is
David LindgrenCenter for Molecular Pathology, Lund University, SwedenVerifierad e-postadress på med.lu.se
Adalgeir ArasonLaboratory of Cell Biology, Department of Pathology, Landspitali - The National University HospitalVerifierad e-postadress på landspitali.is
Mattias AineAffiliated researcher, Division of Oncology & Pathology, Lund UniversityVerifierad e-postadress på med.lu.se
Srinivas Sunny VeerlaScientist, Lund UniversityVerifierad e-postadress på med.lu.se
Fredrik MertensDepartment of Clinical Genetics, Lund UniversityVerifierad e-postadress på med.lu.se
Stina OredssonLund UniversityVerifierad e-postadress på biol.lu.se
Jill HowlinLund UniversityVerifierad e-postadress på med.lu.se
Erik FredlundDept. Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, SwedenVerifierad e-postadress på ki.se
Ingrid HedenfalkDepartment of Oncology, Clinical Sciences, Lund University, SwedenVerifierad e-postadress på med.lu.se
Gottfrid SjödahlAssociate professor, Translational Medicine, Lund UniversityVerifierad e-postadress på med.lu.se

Följ

Johan Staaf

Department of Oncology, Clinical Sciences, Lund University, Sweden

Verifierad e-postadress på med.lu.se - Startsida

Bioinformatics Breast Cancer HER2 Lung Cancer Cancer Genomics


Titel Sortera efter citat Sortera efter år Sortera efter titel	Citeras av Citeras av	År
Landscape of somatic mutations in 560 breast cancer whole-genome sequences S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ... Nature 534 (7605), 47-54, 2016	2323	2016
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures H Davies, D Glodzik, S Morganella, LR Yates, J Staaf, X Zou, ... Nature Medicine 23 (4), 517-525, 2017	1024	2017
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair LH Saal, SK Gruvberger-Saal, C Persson, K Lövgren, M Jumppanen, ... Nature genetics 40 (1), 102-107, 2008	442	2008
GOBO: Gene expression-based Outcome for Breast cancer Online M Ringnér, E Fredlund, J Häkkinen, Å Borg, J Staaf PloS one 6 (3), e17911, 2011	426	2011
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns K Holm, C Hegardt, J Staaf, J Vallon-Christersson, G Jönsson, H Olsson, ... Breast cancer research 12 (3), 1-16, 2010	361	2010
MiRNA expression in urothelial carcinomas: important roles of miR‐10a, miR‐222, miR‐125b, miR‐7 and miR‐452 for tumor stage and metastasis, and frequent homozygous losses of miR‐31 S Veerla, D Lindgren, A Kvist, A Frigyesi, J Staaf, H Persson, F Liedberg, ... International Journal of Cancer 124 (9), 2236-2242, 2009	306	2009
The topography of mutational processes in breast cancer genomes S Morganella, LB Alexandrov, D Glodzik, X Zou, H Davies, J Staaf, ... Nature communications 7, 11383, 2016	288	2016
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study J Staaf, D Glodzik, A Bosch, J Vallon-Christersson, C Reuterswärd, ... Nature medicine 25 (10), 1526-1533, 2019	262	2019
Identification of new MicroRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene H Persson, A Kvist, N Rego, J Staaf, J Vallon-Christersson, L Luts, ... Cancer research 71 (1), 78-86, 2011	256	2011
Research article Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics G Jönsson, J Staaf, J Vallon-Christersson, M Ringnér, K Holm, C Hegardt, ... Breast Cancer Research, 2010	253*	2010
Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma D Lindgren, G Sjödahl, M Lauss, J Staaf, G Chebil, K Lövgren, ... PLoS ONE 7 (6), e38863, 2012	229	2012
Identification of subtypes in human epidermal growth factor receptor 2–positive breast cancer reveals a gene signature prognostic of outcome J Staaf, M Ringnér, J Vallon-Christersson, G Jönsson, PO Bendahl, ... Journal of Clinical Oncology 28 (11), 1813-1820, 2010	229	2010
High‐resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization G Jönsson, J Staaf, E Olsson, M Heidenblad, J Vallon‐Christersson, ... Genes, Chromosomes and Cancer 46 (6), 543-558, 2007	228	2007
Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy H Cirenajwis, H Ekedahl, M Lauss, K Harbst, A Carneiro, J Enoksson, ... Oncotarget 6 (14), 12297, 2015	193	2015
Molecular stratification of metastatic melanoma using gene expression profiling–prediction of survival outcome and benefit from molecular targeted therapy H Cirenajwis, H Ekedahl, M Lauss, K Harbst, A Carneiro, J Enoksson, ... Pigment Cell & Melanoma Research 27 (6), 1181, 2014	193	2014
Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization G Jönsson, TL Naylor, J Vallon-Christersson, J Staaf, J Huang, MR Ward, ... Cancer research 65 (17), 7612-7621, 2005	193	2005
Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays J Staaf, D Lindgren, J Vallon-Christersson, A Isaksson, H Göransson, ... Genome biology 9 (9), 1-18, 2008	173	2008
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer J Staaf, G Jönsson, M Ringnér, J Vallon-Christersson, D Grabau, ... Breast Cancer Research 12 (3), R25, 2010	166	2010
Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios J Staaf, J Vallon-Christersson, D Lindgren, G Juliusson, R Rosenquist, ... BMC bioinformatics 9 (1), 1-11, 2008	165	2008
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics. H Cirenajwis, M Lauss, H Ekedahl, T Törngren, A Kvist, LH Saal, H Olsson, ... Molecular oncology, 2017	153	2017

Systemet kan inte utföra åtgärden just nu. Försök igen senare.

Artiklar 1–20

Citat per år

Dubblettcitat

Sammanfogade citat

Lägg till medförfattareMedförfattare

Följ

Citeras av

Medförfattare